Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 96 of the 101 references it cites were found in a registry or an index; 33 of the 53 sources its claims cite were checked for support.
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that impacts women of reproductive age. In addition to reproductive and psychological complications, women with PCOS are also at a higher risk of developing metabolic diseases such as obesity, type 2 diabetes and cardiovascular disease. While weight reduction can help manage these complications in overweight or obese women, many weight loss interventions have been ineffective due to weight stigma and its psychological impact on women with PCOS. Therefore, exploring alternative dietary strategies which do not focus on weight loss per se is of importance. In this regard, omega-3 polyunsaturated fatty acids of marine origin (n-3 PUFAs), which are known for their hypotriglyceridemic, cardioprotective and anti-inflammatory effects, have emerged as a potential therapy for prevention and reversal of metabolic complications in PCOS. Several clinical trials showed that n-3 PUFAs can improve components of metabolic syndrome in women with PCOS. In this review, we first summarize the available clinical evidence for different dietary patterns in improving PCOS complications. Next, we summarize the clinical evidence for n-3 PUFAs for alleviating metabolic complications in PCOS. Finally, we explore the mechanisms by which n-3 PUFAs improve the metabolic disorders in PCOS in depth.
Overview
CoChat Summary
TL;DR
This is a narrative review arguing that omega-3 polyunsaturated fatty acids, especially marine EPA and DHA, may help improve metabolic dysfunction in PCOS. The paper concludes that n-3 PUFAs can reduce triglycerides, improve insulin resistance, and lower inflammation, but says mechanistic evidence is still limited.
Key findings
- In a meta-analysis of 9 randomized controlled studies (591 women with PCOS), n-3 PUFA supplementation decreased HOMA-IR, total cholesterol, and triglycerides; triglycerides fell by a mean of 29.21 mg/dl (95% CI −48.08, −10.34).
- Another meta-analysis of 11 randomized controlled trials (816 women with PCOS) found beneficial effects of n-3 PUFAs, especially in trials longer than 8 weeks, on HOMA-IR, triglycerides, cholesterol, and adiponectin.
- A meta-analysis of 10 randomized clinical trials reported that n-3 PUFA supplementation decreased hs-CRP and increased adiponectin in women with PCOS.
- In a meta-analysis of 10 randomized controlled trials (610 patients), n-3 PUFA decreased total testosterone and increased SHBG; a cited randomized cross-over study found that 2.4 g/day EPA + DHA for 6 weeks significantly reduced bioavailable testosterone.
Methods
- Narrative review of PCOS diagnosis, pathophysiology, dietary patterns, and the clinical/mechanistic literature on n-3 PUFAs.
- Synthesizes evidence from clinical trials, meta-analyses, cross-sectional/case-control studies, and animal studies; no original participant sample was recruited by this paper.
- Main analysis is qualitative synthesis of reported effects and proposed mechanisms, with specific trial and meta-analysis results summarized in the text.
Limitations
- The paper states that only a few mechanistic studies are available to explain how n-3 PUFAs improve PCOS-related outcomes.
- The paper states that the mechanisms by which n-3 PUFAs reduce androgen production and increase SHBG in PCOS warrant further research.
- Evident from the text: this is a narrative review, so it does not present a new pooled meta-analysis or original dataset of its own.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
28 Valid · 1 Not valid · 12 Not checked · 5 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a case-control study, the PREDIMED score (indicative of the degree of adherence to this dietary pattern) showed a negative correlation with serum testosterone [41]”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 3. Dietary Patterns for Preventing/Treating Metabolic Complications of PCOS > 3.1. Mediterranean Diet
What the sources say
- Supportedcites [41] Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., and Savastano, S. (2019). Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients, 11. source
The Results (Correlation Studies) report a significant negative correlation between PREDIMED score and testosterone levels in women with PCOS after adjustment for BMI and total energy intake. The Results also identify the study groups as 112 PCOS cases and 112 controls. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another meta-analysis of 19 trials comprising 1193 participants confirmed that the DASH diet was superior to other eating patterns in improving insulin resistance in women with PCOS [45].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 3. Dietary Patterns for Preventing/Treating Metabolic Complications of PCOS > 3.2. DASH Diet
What the sources say
- Partly supportedcites [45] Shang, 2020, Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome, J. Clin. Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The Study selection and characteristics section reports 19 trials involving 1,193 women with PCOS. The HOMA-IR results say a subgroup analysis found greater benefit from DASH than from a low-carbohydrate diet, but do not establish superiority over all other eating patterns. The Discussion says DASH only “seemed” more effective, and the Conclusion cautions that more trials are needed; neither presents the finding as confirmed. Page numbers were not available in the supplied passages. (LLM, conf=0.88)
boostedstates a causen = 1,193- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A Cochrane database systematic review including 498 participants from 15 randomized controlled trials showed that lifestyle modification can decrease the free androgen index and body mass index in women with PCOS [33].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 2. PCOS—Diagnosis, Pathophysiology and Management > 2.3. Outline of the Management of PCOS
What the sources say
- Supportedcites [33] Lim, 2019, Lifestyle Changes in Women with Polycystic Ovary Syndrome, Cochrane Database Syst. Rev. source
The Main results section reports 15 studies with 498 participants and says lifestyle intervention may improve free androgen index and reduce BMI in women with PCOS. The Results of the search section identifies the included studies as randomized controlled trials. The 498 participants are the review total, not the number contributing to each outcome analysis. (LLM, conf=0.94)
plainstates a causen = 498- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several clinical studies have demonstrated that n-3 PUFAs can indeed improve various components of the metabolic syndrome, including dyslipidemia, inflammation and insulin resistance in women with PCOS [13].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 1. Introduction
What the sources say
- Partly supportedcites [13] Yang, K., Zeng, L., Bao, T., and Ge, J. (2018). Effectiveness of Omega-3 Fatty Acid for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Reprod. Biol. Endocrinol., 16. sourceExperimental — accuracy not yet measured
The Background reports newer RCTs with beneficial effects on insulin resistance and serum lipids in women with PCOS. The Discussions also describe reduced inflammation, but characterize the meta-analysis findings as effects omega-3 fatty acids *may* have and caution that the trials were small. Saying the studies have demonstrated improvement overstates that uncertainty. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a systematic review of 19 randomized controlled trials including 727 patients with PCOS, the DASH diet was identified as the most effective eating pattern in reducing Homeostatic Model Assessment for Insulin Resistance (HOMA-IR; a marker of insulin resistance) and serum triglycerides [44].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 3. Dietary Patterns for Preventing/Treating Metabolic Complications of PCOS > 3.2. DASH Diet
What the sources say
- Supportedcites [44] Stubnya, 2024, Ranking the Dietary Interventions by Their Effectiveness in the Management of Polycystic Ovary Syndrome: A Systematic Review and Network Meta-Analysis, Reprod. Health source
The Abstract’s Results section reports 19 RCTs comprising 727 patients and ranks the DASH diet as most effective for reducing both HOMA-IR and triglyceride levels. The Discussion gives a different patient count (708), but the claimed count is explicitly stated in the Abstract. (LLM, conf=0.95)
plainstates a causen = 727- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
18 more claims · 9 with their cited sources checked
Create a free account to see all 46 claims and to verify the 7 references still open.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 2
Citations
Cites
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · cited 1×
“…ester (icosapent ethyl—4 g/day) reduced major cardiovascular events in patients with existing cardiovascular disease or diabetes and elevated plasma triglycerides [81], confirming that the triglyceride-lowering effects of these fatty acids also extend into cardio-protection in the longer term.”
BackgroundOh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428 · cited 1×
“Further, EPA/DHA are potent activators of the G protein-coupled receptor 120 (GPR120), which has potent anti-inflammatory effects, particularly against macrophage-induced tissue inflammation [92].”
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · cited 2×
“An intricate interplay between neuroendocrine disruptions and insulin resistance is likely responsible for the heterogeneity of PCOS presentation Previous reviews have discussed these mechanisms in detail [3,14] and a brief outline is provided below and illustrated in Figure 1. women.”
BackgroundOmega-3 fatty acids EPA and DHA: Health benefits throughout life
Swanson, D., Block, R., & Mousa, S. A. (2012) · Advances in Nutrition · doi:10.3945/an.111.000893 · Cited by 1,575 · cited 1×
“For example, the anti-inflammatory, hypotriglyceri-demic, and cardioprotective effects of n -3 PUFA have been mainly demonstrated for EPA and DHA [61].”
BackgroundCriteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · cited 1×
“Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age with a prevalence ranging from 4 to 21% depending on the diagnostic criteria used [1].”
BackgroundResolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“Resolvins, protectins, and maresins are EPA/DHA-derived SPMs, which enhance the resolution phase of inflammation [88].”
BackgroundThe Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245 · cited 1×
“Both classes are considered essential fatty acids because the human body cannot synthesize sufficient amounts of these fatty acids de novo [55].”
BackgroundDistribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162 · cited 2×
“Further, while LA can be converted to AA and ALA can be converted to EPA and then DHA, respectively, this conversion is inefficient in humans [59] and is unlikely to lead to high AA and EPA/DHA levels in the body.”
BackgroundThe role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136 · cited 1×
“Obesity also gives rise to ectopic lipid deposition in the liver and skeletal muscle, leading to lipotoxicity, which in turn can lead to insulin resistance [22].”
BackgroundDinu, M., Pagliai, G., Casini, A., & Sofi, F. (2018) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.58 · Cited by 1,016
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad463 · Cited by 946 · cited 10×
“Further, dietary changes, even in the absence of weight loss, improve PCOS complications [2].”
BackgroundMethodInfluentialBrenna, J. T., Salem, N., Sinclair, A. J., & Cunnane, S. C. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.01.004 · Cited by 863 · cited 1×
“It is important to recognize that not all n -3 PUFAs have the same biological effects [60].”
BackgroundLifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · cited 1×
“To this end, cultured fibroblasts and skeletal muscle from women with PCOS showed increased serine phosphorylation and decreased tyrosine phosphorylation of the insulin receptor, suggesting another mechanism for insulin resistance [24].”
BackgroundSanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557 · cited 1×
“Elevated levels of androgens in PCOS can also lead to insulin resistance [25].”
BackgroundRimm, E. B., Appel, L. J., Chiuve, S. E., Djoussé, L., Engler, M. B., Kris-Etherton, P. M., Mozaffarian, D., Siscovick, D. S., Lichtenstein, A. H., & On behalf of the American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology (2018) · Circulation · doi:10.1161/cir.0000000000000574 · Cited by 500 · cited 1×
“Detailed information on the EPA and DHA content of commonly consumed seafood is given by Rimm et al. [57].”
BackgroundEFSA Panel on Dietetic Products, N. A. A. (. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2815 · Cited by 370 · cited 2×
“While no tolerable upper intake level (UL) has been set for these fatty acids, up to 5 g/day of combined EPA and DHA is considered safe by the European Food Safety Authority [58].”
BackgroundOmega-3 fatty acids in obesity and metabolic syndrome: A mechanistic update
Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., Rahman, S. M., Robert-McComb, J., & Moustaid-Moussa, N. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.012 · Cited by 355
Self-citationBoulman, N., Levy, Y., Leiba, R., Shachar, S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 330 · cited 1×
“Indeed, inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) and interleukins are elevated in PCOS [27], which can interfere with insulin signaling pathways.”
BackgroundBarrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., & Savastano, S. (2019) · Nutrients · doi:10.3390/nu11102278 · Cited by 306 · cited 2×
“Some nutrients in this dietary pattern, such as n -3 PUFAs, reduce inflammation and enhance insulin sensitivity, while saturated fats, which are present in high amounts in Western diets, are linked to increased testosterone levels [41].”
Background(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305 · cited 2×
“…adipokine and a known insulin sensitizer, the beneficial effects of n -3 PUFA, mainly EPA/DHA, on inflammation and insulin resistance is likely at least in part mediated via increased serum adiponectin. n -3 PUFAs of marine origin have known anti-inflammatory effects on adipose tissue [12].”
BackgroundSelf-citationImmunity as a link between obesity and insulin resistance
Kalupahana, N. S., Moustaid-Moussa, N., & Claycombe, K. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.011 · Cited by 253 · cited 1×
“Obesity also leads to adipose tissue inflammation and dysfunction, which leads to increased free fatty acids, higher pro-inflammatory cytokines, and lower anti-inflammatory adipokines, such as adiponectin, leading to systemic insulin resistance [21].”
BackgroundSelf-citationMarsh, K. A., Steinbeck, K. S., Atkinson, F. S., Petocz, P., & Brand-Miller, J. C. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29261 · Cited by 228 · cited 1×
“Research indicates that compared to conventional diets, low-GI diets are more successful at reducing inflammation [50] and increasing insulin sensitivity [51] in women with PCOS.”
BackgroundChiavaroli, L., Lee, D., Ahmed, A., Cheung, A., Khan, T. A., Blanco, S., Mejia, Mirrahimi, A., Jenkins, D. J. A., Livesey, G., et al. (2021) · BMJ · doi:10.1136/bmj.n1651 · Cited by 215 · cited 1×
“Since this eating pattern provides benefits in improving glycemic control, dyslipidemia, blood pressure, and inflammation in patients with diabetes mellitus [49], it is potentially an important dietary pattern for women with PCOS as well.”
BackgroundRett, B. S., & Whelan, J. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-36 · Cited by 210
Qu, X., & Donnelly, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218191 · Cited by 210 · cited 1×
“Thus, lower SHBG levels result in higher free androgen levels in the blood increasing their androgenic effects [32].”
BackgroundCussons, A. J., Watts, G. F., Mori, T. A., & Stuckey, B. G. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0870 · Cited by 180
Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome
Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa425 · Cited by 171 · cited 1×
“Another meta-analysis of 19 trials comprising 1193 participants confirmed that the DASH diet was superior to other eating patterns in improving insulin resistance in women with PCOS [45].”
BackgroundVlachos, D., Malisova, S., Lindberg, F. A., & Karaniki, G. (2020) · Nutrients · doi:10.3390/nu12061561 · Cited by 166 · cited 2×
“The low-GI diet, which focuses on slowly digested carbohydrates, has been shown to improve lipid profiles, insulin sensitivity, and blood glucose control, among other health outcomes [48].”
BackgroundWang, T., Sha, L., Li, Y., Zhu, L., Wang, Z., Li, K., Lu, H., Bao, T., Guo, L., Zhang, X., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00284 · Cited by 162 · cited 1×
“In another study using a letrozole-induced PCOS rat model, fish oil supplementation ameliorated the defects in ovarian morphology and estrous cycle, which was associated with reduced ovarian and systemic inflammatory markers, serum LPS levels, and a favorable change in gut microbiota [94].”
BackgroundWang, X., Walsh, L. P., Reinhart, A. J., & Stocco, D. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003113200 · Cited by 161 · cited 1×
“This AA effect is at least in part via the regulation of steroidogenic acute regulatory protein (StAR) expression [83].”
BackgroundThe adrenal and polycystic ovary syndrome
Yıldız, B. O., & Azziz, R. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9054-0 · Cited by 149 · cited 1×
“Increased ovarian androgen production, coupled with increased production of adrenal androgens, leads to hyperandrogenism [16], which gives rise to hirsutism, acne, and alopecia in these women.”
BackgroundNutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome
Alesi, S., Ee, C., Moran, L. J., Rao, V., & Mousa, A. (2022) · Advances in Nutrition · doi:10.1093/advances/nmab141 · Cited by 146 · cited 2×
“Potential benefits of dietary supplements in the management of PCOS have been previously reviewed by Iervolino et al. [54] and Alesi et al. [18].”
BackgroundRecent advances in the understanding and management of polycystic ovary syndrome
Rocha, A. L., Oliveira, F. R., Azevedo, R. C., Silva, V. A., Peres, T. M., Candido, A. L., Gomes, K. B., & Reis, F. M. (2019) · F1000Research · doi:10.12688/f1000research.15318.1 · Cited by 142 · cited 1×
“In overweight or obese women, weight loss induced by dietary changes reduces the level of androgen, insulin resistance and the risk for other complications [4].”
BackgroundAsemi, Z., Samimi, M., Tabassi, Z., Shakeri, H., Sabihi, S.-S., & Esmaillzadeh, A. (2014) · Nutrition · doi:10.1016/j.nut.2014.03.008 · Cited by 136 · cited 1×
“Other clinical studies have shown that adhering to the DASH diet leads to reductions in inflammatory markers such as hs-CRP and modest decreases in body weight and waist circumference [46,47].”
BackgroundAsemi, Z., & Esmaillzadeh, A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0034-1376990 · Cited by 134 · cited 1×
“Other clinical studies have shown that adhering to the DASH diet leads to reductions in inflammatory markers such as hs-CRP and modest decreases in body weight and waist circumference [46,47].”
BackgroundPolycystic Ovary Syndrome: Pathophysiology and Therapeutic Opportunities
Dong, J., & Rees, D. A. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000548 · Cited by 123
Karimzadeh, M. A., & Javedani, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.078 · Cited by 118
Insulin Resistance and Hyperinsulinemia
Kim, S. H., & Reaven, G. M. (2008) · Diabetes Care · doi:10.2337/dc08-0045 · Cited by 116 · cited 1×
“In states of insulin resistance, there is compensatory hyperinsulinemia [29], which in turn can increase ovarian androgen production [30].”
BackgroundVictor, V. M., Rovira-Llopis, S., Bañuls, C., Diaz-Morales, N., Martinez de Marañon, A., Rios-Navarro, C., Alvarez, A., Gomez, M., Rocha, M., & Hernández-Mijares, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151960 · Cited by 112 · cited 1×
“Chronic systemic low-grade inflammation and increased oxidative stress, which are often present in PCOS, can also lead to insulin resistance [26].”
BackgroundHypothalamic mechanisms of obesity-associated disturbance of hypothalamic–pituitary–ovarian axis
Chen, X., Xiao, Z., Cai, Y., Huang, L., & Chen, C. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.12.004 · Cited by 112 · cited 4×
“…axis is the primary regulator of reproductive function in women In eumenorrheic women, a pulsatile secretion of gonadotropin-releasing hormone (GnRH) stimulates the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary [15].”
BackgroundInfluentialMohammadi, E., Rafraf, M., Farzadi, L., Jafarabadi, M. A., & Sabour, S. (2012) · PubMed · Cited by 111
Hyperinsulinemia and Ovarian Hyperandrogenism: Cause and Effect
Barbieri, R. L., & Hornstein, M. D. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30405-5 · Cited by 108 · cited 1×
“In states of insulin resistance, there is compensatory hyperinsulinemia [29], which in turn can increase ovarian androgen production [30].”
BackgroundYang, K., Zeng, L., Bao, T., & Ge, J. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0346-x · Cited by 103 · cited 4×
“Several clinical studies have demonstrated that n -3 PUFAs can indeed improve various components of the metabolic syndrome, including dyslipidemia, inflammation and insulin resistance in women with PCOS [13].”
BackgroundMethodResultInfluentialKazemi, M., Hadi, A., Pierson, R. A., Lujan, M. E., Zello, G. A., & Chilibeck, P. D. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa092 · Cited by 102 · cited 2×
“These diets have also been connected to better satiety, reduced overall calorie consumption, and improved weight management—all of which are critical for controlling the metabolic issues related to PCOS [53].”
BackgroundNatural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
Iervolino, M., Lepore, E., Forte, G., Laganà, A. S., Buzzaccarini, G., & Unfer, V. (2021) · Nutrients · doi:10.3390/nu13051677 · Cited by 98 · cited 1×
“Potential benefits of dietary supplements in the management of PCOS have been previously reviewed by Iervolino et al. [54] and Alesi et al. [18].”
BackgroundAdipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome
Dumesic, D. A., Phan, J. D., Leung, K. L., Grogan, T. R., Ding, X., Li, X., Hoyos, L. R., Abbott, D. H., & Chazenbalk, G. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02086 · Cited by 92 · cited 1×
“It is important to point out, however, that even normal-weight women with PCOS have insulin resistance [23], suggesting that adiposity-independent mechanisms may also play a role in the pathogenesis of insulin resistance in this condition.”
BackgroundMitochondrial Dysfunction in PCOS: Insights into Reproductive Organ Pathophysiology
Siemers, K. M., Klein, A. K., & Baack, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713123 · Cited by 91 · cited 1×
“Finally, mitochondrial dysfunction, which impairs cellular energy metabolism, has been implicated in the pathophysiology of insulin resistance in PCOS [28].”
BackgroundMohammadi, E., Rafraf, M., Farzadi, L., Asghari-Jafarabadi, M., & Sabour, S. (2012) · Asia Pacific Journal of Clinical Nutrition · doi:10.6133/apjcn.2012.21.4.06 · Cited by 91
Jamilian, M., Samimi, M., Mirhosseini, N., Afshar Ebrahimi, F., Aghadavod, E., Talaee, R., Jafarnejad, S., Hashemi Dizaji, S., & Asemi, Z. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.027 · Cited by 89
Phelan, N., O’Connor, A., Kyaw Tun, T., Correia, N., Boran, G., Roche, H. M., & Gibney, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005538 · Cited by 89 · cited 3×
“Mechanistically, the reduced testosterone in the n -3 PUFA group is likely to be due to a reduced n -6: n -3 ratio leading to reduced availability of AA in cell membranes (Figure 2), since n -6 PUFA treatment was shown to increase androstenedione secretion from bovine theca cells in vitro [68].”
BackgroundInfluentialYannakoulia, M., & Scarmeas, N. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2211889 · Cited by 89
Dietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome
Che, X., Chen, Z., Liu, M., & Mo, Z. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000519302 · Cited by 87 · cited 2×
“The Med diet offers significant health benefits, including lowered risks of chronic diseases such as type 2 diabetes, cardiovascular disease, and certain cancers, while also improving longevity and cognitive function [40].”
BackgroundRahmani, E., Samimi, M., Ebrahimi, F. A., Foroozanfard, F., Ahmadi, S., Rahimi, M., Jamilian, M., Aghadavod, E., Bahmani, F., Taghizadeh, M., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.09.008 · Cited by 86
Vargas, M. L., Almario, R. U., Buchan, W., Kim, K., & Karakas, S. E. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.007 · Cited by 86
Mourente, G., & Tocher, D. R. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90195-3 · Cited by 86 · cited 2×
“As mentioned before, EPA and DHA directly compete with AA for incorporation to cell membranes, while ALA indirectly reduces AA via competing with delta 6 desaturase, the enzyme which converts LA to AA [84].”
BackgroundAbdolahian, S., Tehrani, F. R., Amiri, M., Ghodsi, D., Yarandi, R. B., Jafari, M., Majd, H. A., & Nahidi, F. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00552-1 · Cited by 84 · cited 1×
“Lifestyle change is not only important to improve reproductive and androgenic features but also to improve metabolic health [34] and cardiovascular disease risk factors such as dyslipidemia [35,36].”
BackgroundWu, J. H. Y., Cahill, L. E., & Mozaffarian, D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3899 · Cited by 83 · cited 1×
“A meta-analysis of 14 randomized controlled trials showed that fish oil significantly increased serum adiponectin levels [91].”
Ovarian actions of resveratrol
Ortega, I., & Dulęba, A. J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12875 · Cited by 80 · cited 1×
“While several dietary bioactive compounds, such as the polyphenol resveratrol, have evidence for benefits in POCS [8], the potential teratogenicity of some of these compounds, especially in the context of women who are of reproductive age who may become pregnant, makes their applications…”
BackgroundRegidor, P., Mueller, A., Sailer, M., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010384 · Cited by 76 · cited 1×
“Detailed effects of SPMs on PCOS have been reviewed by Regidor et al. previously [89].”
BackgroundKim, C. H., Chon, S. J., & Lee, S. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-64776-w · Cited by 73 · cited 1×
“Lifestyle change is not only important to improve reproductive and androgenic features but also to improve metabolic health [34] and cardiovascular disease risk factors such as dyslipidemia [35,36].”
BackgroundOmega-3 Fatty Acids and Adipose Tissue: Inflammation and Browning
Kalupahana, N. S., Goonapienuwala, B. L., & Moustaid-Moussa, N. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-122319-034142 · Cited by 72 · cited 1×
“…adjunct therapy for women with PCOS not only for reducing the clinical features of this condition but also for reducing cardiovascular disease risk. n -3 PUFAs are well known for their anti-inflammatory, cardioprotective and hypotriglyceridemic effects, which we have reviewed previously [10–12].”
BackgroundSelf-citationRafraf, M., Mohammadi, E., Asghari-Jafarabadi, M., & Farzadi, L. (2012) · Journal of the American College of Nutrition · doi:10.1080/07315724.2012.10720443 · Cited by 70
Efficacy of omega-3 in the treatment of polycystic ovary syndrome
Oner, G., & Muderris, I. I. (2013) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2012.751365 · Cited by 68
Preconception resveratrol intake against infertility: Friend or foe?
Ochiai, A., & Kuroda, K. (2019) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12303 · Cited by 67 · cited 1×
“…several dietary bioactive compounds, such as the polyphenol resveratrol, have evidence for benefits in POCS [8], the potential teratogenicity of some of these compounds, especially in the context of women who are of reproductive age who may become pregnant, makes their applications problematic [9].”
BackgroundMirmasoumi, G., Fazilati, M., Foroozanfard, F., Vahedpoor, Z., Mahmoodi, S., Taghizadeh, M., Esfeh, N. K., Mohseni, M., Karbassizadeh, H., & Asemi, Z. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-119751 · Cited by 64
Shang, Y., Zhou, H., He, R., & Lu, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735954 · Cited by 61 · cited 1×
“A meta-analysis of 20 randomized controlled trials comprising a total of 1113 women with PCOS showed that dietary modifications improved pregnancy rate and menstrual regularity with reductions in clinical features of hyperandrogenisms such as hirsutism [38].”
Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome
Khani, B., Mardanian, F., & Fesharaki, S. J. (2017) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_644_16 · Cited by 59
Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines
Bornfeldt, K. E. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147558 · Cited by 58 · cited 2×
“Mechanistically, n -3 PUFAs reduce plasma triglycerides by increasing fatty acid oxidation, thereby inhibiting hepatic lipogenesis and VLDL cholesterol production [80].”
BackgroundShaaban, Z., Khoradmehr, A., Amiri‐Yekta, A., Nowzari, F., Shirazi, M. R. J., & Tamadon, A. (2021) · Genetics Research · doi:10.1155/2021/7781823 · Cited by 56 · cited 1×
“Genetic studies have shown that several genes associated with insulin resistance are also linked to PCOS [17], suggesting a common origin of neuroendocrine dysregulations and insulin resistance in this condition.”
BackgroundKazemi, M., Jarrett, B. Y., Vanden Brink, H., Lin, A. W., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2020) · Nutrients · doi:10.3390/nu12071953 · Cited by 53 · cited 1×
“It was observed that higher adherence to the Med diet was associated with decreased waist circumference, reduced ovarian volume, and lowered PCOS severity [42].”
BackgroundNadjarzadeh, A., Firouzabadi, R. D., Daneshbodi, H., Lotfi, M. H., Vaziri, N., & Mozaffari–Khosravi, H. (2015) · PubMed Central · Cited by 50
Szczuko, M., Zapalowska-Chwyć, M., & Drozd, R. (2019) · Molecules · doi:10.3390/molecules24081508 · Cited by 45 · cited 1×
“Research indicates that compared to conventional diets, low-GI diets are more successful at reducing inflammation [50] and increasing insulin sensitivity [51] in women with PCOS.”
BackgroundTosatti, J. A. G., Alves, M. T., Cândido, A. L., Reis, F. M., Araújo, V. E., & Gomes, K. B. (2021) · British Journal of Nutrition · doi:10.1017/s0007114520003207 · Cited by 38 · cited 1×
“A meta-analysis of 10 randomized clinical trials showed that n -3 PUFA supplementation decreased serum hs-CRP and increased serum adiponectin levels [90], confirming the benefit of n -3 PUFAs in reducing systemic inflammation in women with PCOS.”
MethodHow to manage weight loss in women with obesity and PCOS seeking fertility?
Hazlehurst, J. M., Singh, P., Bhogal, G., Broughton, S., & Tahrani, A. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14726 · Cited by 37 · cited 2×
“While dietary strategies are effective for weight reduction in women who are overweight or obese, the widespread problem of weight stigma and its detrimental psychological effects, as well as weight regain, compromises their efficacy [2,5,6].”
BackgroundJurczewska, J., Ostrowska, J., Chełchowska, M., Panczyk, M., Rudnicka, E., Kucharski, M., Smolarczyk, R., & Szostak-Węgierek, D. (2023) · Nutrients · doi:10.3390/nu15163652 · Cited by 37 · cited 1×
“Obesity, especially abdominal obesity, can contribute to insulin resistance [19] and other cardiovascular risk factors [20] in women with PCOS.”
BackgroundWang, X., Walsh, L. P., & Stocco, D. M. (1999) · Endocrine · doi:10.1385/endo:10:1:7 · Cited by 34 · cited 1×
“Previous studies have shown that AA is important for LH-stimulated steroidogenesis in vitro [82].”
BackgroundJuhász, A. E., Stubnya, M. P., Teutsch, B., Gede, N., Hegyi, P., Nyirády, P., Bánhidy, F., Ács, N., & Juhász, R. (2024) · Reproductive Health · doi:10.1186/s12978-024-01758-5 · Cited by 32 · cited 1×
“In a systematic review of 19 randomized controlled trials including 727 patients with PCOS, the DASH diet was identified as the most effective eating pattern in reducing Homeostatic Model Assessment for Insulin Resistance (HOMA-IR; a marker of insulin resistance) and serum triglycerides [44].”
BackgroundBiernacka-Bartnik, A., Kocełak, P., Owczarek, A. J., Choręza, P. S., Puzianowska‐Kuźnicka, M., Markuszewski, L., Madej, P., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2022) · International Journal of Endocrinology · doi:10.1155/2022/6498768 · Cited by 30 · cited 1×
“Hyperinsulinemia can also lead to a reduction in sex hormone-binding globulin (SHBG) production by the liver, leading to low serum SHBG levels [31].”
BackgroundMoslehi, N., Zeraattalab-Motlagh, S., Rahimi Sakak, F., Shab-Bidar, S., Tehrani, F. R., & Mirmiran, P. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuac075 · Cited by 28 · cited 2×
“Numerous randomized controlled trials (Table 2) and meta-analyses of those trials [13,65] have shown that n -3 PUFAs (either ALA or EPA/DHA) are effective in reducing serum triglycerides in women with PCOS.”
BackgroundZhang, H., Zheng, L., Li, C., Jing, J., Li, Z., Sun, S., Xue, T., Zhang, K., Xue, M., Cao, C., et al. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01227-w · Cited by 27 · cited 2×
“In a DHEA-induced PCOS mouse model, eight weeks of n -3 PUFA supplementation was able to reverse the DHEA-induced increases in serum LH levels as well as insulin resistance and ovarian dysfunction [93].”
BackgroundTalari, H. R., Poladchang, S., Hamidian, Y., Samimi, M., Gilasi, H. R., Ebrahimi, F. A., & Asemi, Z. (2018) · Oman Medical Journal · doi:10.5001/omj.2018.88 · Cited by 26
Xia, Y., Wang, Y., Cui, M., & Su, D. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1050 · Cited by 23 · cited 2×
“Another meta-analysis of 10 randomized controlled trials, including 778 women with PCOS, also showed a reduction in serum hs-CRP following n -3 PUFA supplementation [66].”
MethodResultYuan, J., Wen, X., & Jia, M. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2018 · Cited by 22 · cited 1×
“The same meta-analysis mentioned above in Section 4.3.2 reported that n -3 PUFA reduces serum hs-CRP and malondialdehyde while improving serum total antioxidant capacity [86].”
MethodInfluentialLu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1016943 · Cited by 22 · cited 1×
“…included 185 women with PCOS from China, found that both dietary n -3 PUFA intake as well as serum n -3 PUFA, especially EPA and DHA levels, were negatively correlated with HOMA-IR index and body fat levels [63], suggesting that n -3 PUFA may help in improving insulin resistance among these women.”
BackgroundSordia-Hernández, L. H. S.-H., Rodríguez, P. A. R., Rodriguez, D. S., Guzmán, S. T. G., Zenteno, E. S. S., González, G. G. G., & Patiño, R. I. P. (2016) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog3037.2016 · Cited by 21 · cited 1×
“Low-GI diets have also been demonstrated to increase ovulation and decrease anovulation in PCOS patients [52].”
BackgroundDietary and serum n -3 PUFA and polycystic ovary syndrome: a matched case–control study
Lu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C. (2022) · British Journal of Nutrition · doi:10.1017/s0007114521003007 · Cited by 20 · cited 2×
“A case-control study of 325 pairs of women with PCOS and healthy controls from China showed that women in the highest tertile of serum phospholipid n -3 PUFAs were 40% less likely to have PCOS compared to those in the lowest tertile [62].”
BackgroundThe effects of fish oil on gene expression in patients with polycystic ovary syndrome
Rahmani, E., Jamilian, M., Dadpour, B., Nezami, Z., Vahedpoor, Z., Mahmoodi, S., Aghadavod, E., Taghizadeh, M., Hassan, A. B., & Asemi, Z. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12893 · Cited by 19
Sheikh, J., Khalil, H., Shaikh, S., Hebbar, M., Zia, N., Wicks, S., Jayaprakash, S., Narendran, A., Subramanian, A., Malhotra, K., et al. (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17428 · Cited by 18 · cited 1×
“While dietary strategies are effective for weight reduction in women who are overweight or obese, the widespread problem of weight stigma and its detrimental psychological effects, as well as weight regain, compromises their efficacy [2,5,6].”
BackgroundZhou, J., Zuo, W., Tan, Y., Wang, X., Zhu, M., & Zhang, H. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01130-4 · Cited by 16
Fonseka, S., Wijeyaratne, C. N., Gawarammana, I., Kalupahana, N. S., Rosairo, S., Ratnatunga, N. V. I., & Kumarasiri, R. (2020) · PubMed · Cited by 16
Self-citationResolvin D1 impacts on insulin resistance in women with polycystic ovary syndrome and healthy women
Morshedzadeh, N., Saedisomeolia, A., Djalali, M., Eshraghian, M. R., Hantoushzadeh, S., & Mahmoudi, M. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.018 · Cited by 12 · cited 1×
“…29 matched-controls, plasma-resolving D1 level showed a strong negative correlation with the HOMA–IR index in both women with PCOS as well as controls [87] suggesting that this DHA-derived specialized pro-resolving mediator (SPM) may be important in improving insulin resistance in women with PCOS.”
BackgroundScannell, N., Mantzioris, E., Rao, V. S., Pandey, C., Ee, C., Mousa, A., Moran, L., & Villani, A. M. (2023) · Biomedicines · doi:10.3390/biomedicines11123349 · Cited by 12 · cited 1×
“Indeed, a myriad of dietary supplements are already used by patients with PCOS [7], albeit unsupported by clinical evidence in some instances.”
Fonseka, S., Subhani, B., Wijeyaratne, C. N., Gawarammana, I., Kalupahana, N. S., Ratnatunga, N. V. I., Rosairo, S., & Vithane, K. P. (2019) · Ceylon Medical Journal · doi:10.4038/cmj.v64i3.8958 · Cited by 11 · cited 1×
“Obesity, especially abdominal obesity, can contribute to insulin resistance [19] and other cardiovascular risk factors [20] in women with PCOS.”
BackgroundSelf-citationMitochondrial Dysfunction in PCOS: Insights into Reproductive Organ PathophysiologyPreprint
Siemers, K. M., Klein, A. K., & Baack, M. L. (2023) · Preprints.org · doi:10.20944/preprints202307.1807.v2 · Cited by 9
Mirmasoumi, G., Fazilati, M., Foroozanfard, F., Vahedpoor, Z., Mahmoodi, S., Taghizadeh, M., Esfeh, N. K., Mohseni, M., Karbassizadeh, H., & Asemi, Z. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1736-9017
Cited by
The Role of Lifestyle Interventions in PCOS Management: A Systematic Review
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115
“Omega-3 fatty acids have powerful anti-inflammatory properties that can improve insulin sensitivity and decrease androgen levels in metabolic syndromes like PCOS [121].”
Merza, W. M., Yaseen, A. K., & Mahmood, M. A. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106773 · Cited by 27
Gautam, R., Bhateja, A., Malhotra, N., & Arora, T. K. (2025) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2025.102024 · Cited by 9
Tarantino, G., & Citro, V. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.119467 · Cited by 19
Sangeetha, A. L., & Geetha, P. (2024) · International Conference on Data Intelligence and Cognitive Informatics (ICDICI) · doi:10.1109/icdici62993.2024.10810804 · Cited by 5
Metadata
- Authors
- Albardan, L., Platat, C., & Kalupahana, N. S.
- Affiliations
- United Arab Emirates University (AE)
- Corresponding author
- Kalupahana, Nishan Sudheera
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2024-09-03
- Volume
- 16
- Issue
- 17
- Pages
- 2961
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC11397015
- OpenAlex
- W4402198951
- Cited by
- 18
- References
- 101
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 3
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- United Arab Emirates University (G00004624)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, omega-3 fatty acids, metabolic dysfunction, metabolic syndrome, obesity, type 2 diabetes, cardiovascular disease, dietary intervention, weight stigma, anti-inflammatory activity, hypotriglyceridemic effect, cardioprotection
- MeSH terms
- Female, Humans, Obesity, Polycystic Ovary Syndrome, Fatty Acids, Omega-3, Dietary Supplements, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

